ID: MRFR/Pharma/4960-HCR | February 2021 | Region: Global | 90 pages
The mouth ulcer treatment market is expected to register a CAGR of ~ 4 % during the forecast period from 2018 to 2023. Mouth ulcers are painful sores that can develop in the mucous membrane of the oral cavity and this restrict the ability to chew, bite or eat. Some factors which result in mouth ulcer are stress, infection, injury, allergy, and others which leads to intense pain. Increasing use of synthetics in oral items such as toothpaste and growing unhealthy lifestyle, including high consumption of junk food and tobacco are some of the factors driving the growth of this market. Mouth ulcer can be prevented by avoiding tissue injury, avoiding the food that causes irritation in mouth and maintaining oral hygiene. Besides the traditional method, various drugs are used to treat mouth ulcer. Increasing aging population and increasing incidences of mouth ulcer are driving the growth of this mouth ulcer treatment market.
However, people have a very casual approach towards mouth ulcer, which can lead to negative impact on the growth of the market in future.
The mouth ulcer treatment market has been segmented on basis of drug type, formulation, and indication. On basis of drug type, the market is segmented into corticosteroid, antihistamine, antimicrobial, analgesic, and anesthetic. Based on formulation, the market is segmented into gel, mouthwash, ointment, spray, and lozenges. Based on indication market is segmented into Aphthous Stomatitis, Oral Lichen Planus and Others.
Key players in the mouth ulcer treatment market are Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company
Regional Market Summary
Global Mouth Ulcer Treatment Market Share (%), by Region, 2018
Source: World Health Organization (WHO)
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The mouth ulcer treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The mouth ulcer treatment market in the Middle East and Africa has been segmented into the Middle East and Africa.
On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and the Middle East and Africa. North America market is anticipated to dominate the mouth ulcer treatment market due to advanced technology made in diagnostic procedures of oral and dental care. Growing awareness among consumers regarding the availability of mouth ulcer treatment is the key share to increase the growth of the market in North America. Europe is anticipated to drive the growth of mouth ulcer treatment in upcoming years due to increasing incidences of an aging population suffering from mouth ulcer. Asia-Pacific is projected to register a robust growth due to increasing initiatives of government regarding mouth ulcer and increasing patients with mouth ulcer cases. The Middle East and Africa is expected to account for the lowest market share in the market due to lack of advanced technology and poor medical facilities in developing economies in this region.
Market of Mouth Ulcer Treatment, by Drug Type
Market of Mouth Ulcer Treatment, by Formulation
Market of Mouth Ulcer Treatment, by Indications
Market of Mouth Ulcer Treatment, by Region
Middle East & Africa
|Market Size||2027: Significant Value|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Drug Type, Formulation, and Indication|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Pfizer, Inc., Church & Dwight Co., Inc., 3M, Taro Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, BLISTEX, INC., GlaxoSmithKline plc., ECR Pharmaceuticals, Sannova, Reckitt Benckiser, Sunstar, Blairex Laboratories, Sanjin Pharmaceutical, Joincare Pharmaceutical, Sinclair Pharma, Colgate-Palmolive Company|
|Key Market Opportunities||
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Casual approach taken by most patients towards mouth ulcers is the key restraint on the market, as this stops patients from seeking out recognized medication.
Mouth Ulcer Treatment Market is expected to exhibit a steady 4% CAGR over the forecast period from 2020 to 2027.
Growing prevalence of mouth ulcers is likely to be a major driver for the market.
Americas hold the largest share in the global mouth ulcer treatment market.
Leading players in the Mouth Ulcer Treatment Market include BLISTEX Inc., 3M, and Pfizer, among others.